7,105
Views
57
CrossRef citations to date
0
Altmetric
Review

Visual Impairment and Mental Health: Unmet Needs and Treatment Options

& ORCID Icon
Pages 4229-4251 | Published online: 03 Dec 2020

References

  • World Report on Vision. World Health Organization; 2019.
  • Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Global Health. 2017;5(9):e888–e897. doi:10.1016/S2214-109X(17)30293-0
  • Pelletier AL, Rojas-Roldan L, Coffin J. Vision Loss in Older Adults. Am Fam Physician. 2016;94(3):219–226.
  • Gordois A, Cutler H, Pezzullo L, et al. An estimation of the worldwide economic and health burden of visual impairment. Glob Public Health. 2012;7(5):465–481. doi:10.1080/17441692.2011.634815
  • Khorrami-Nejad M, Sarabandi A, Akbari M-R, Askarizadeh F. The impact of visual impairment on quality of life. Med Hypothesis Discov Innov Ophthalmol. 2016;5(3):96–103.
  • Dhital A, Pey T, Stanford MR. Visual loss and falls: a review. Eye. 2010;24(9):1437–1446. doi:10.1038/eye.2010.60
  • Brunes A, Hansen B, Heir T. Loneliness among adults with visual impairment: prevalence, associated factors, and relationship to life satisfaction. Health Qual Life Outcomes. 2019;17(1). doi:10.1186/s12955-019-1096-y
  • Nyman SR, Gosney MA, Victor CR. Psychosocial impact of visual impairment in working-age adults. Br J Ophthalmol. 2010;94(11):1427–1431. doi:10.1136/bjo.2009.164814
  • Choi HG, Lee MJ, Lee S-M. Visual impairment and risk of depression: A longitudinal follow-up study using a national sample cohort. Sci Rep. 2018;8:1. doi:10.1038/s41598-018-20374-5
  • Mayro EL, Murchison AP, Hark LA, et al. Prevalence of depressive symptoms and associated factors in an urban, ophthalmic population. Eur J Ophthalmol. 2020:112067212090170. doi:10.1177/1120672120901701.
  • Zhang X, Bullard KM, Cotch MF, et al. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. JAMA Ophthalmol. 2013;131(5):573. doi:10.1001/jamaophthalmol.2013.2597
  • Rees G, Tee HW, Marella M, Fenwick E, Dirani M, Lamoureux EL. Vision-specific distress and depressive symptoms in people with vision impairment. Invest Opthalmol Visual Sci. 2010;51(6):2891. doi:10.1167/iovs.09-5080
  • Li W, Zhong B, Liu X, et al. Depressive symptoms among the visually disabled in Wuhan: an epidemiological survey. Shanghai Arch Psychiatry. 2013;25(5):306–313. doi:10.3969/j.issn.1002-0829.2013.05.006
  • Stevelink SAM, Fear NT. Psychosocial impact of visual impairment and coping strategies in female ex-Service personnel. J R Army Med Corps. 2016;162(2):129–133. doi:10.1136/jramc-2015-000518
  • Schuster AK, Tesarz J, Rezapour J, Beutel ME, Bertram B, Pfeiffer N. Visual impairment is associated with depressive symptoms—results from the Nationwide German DEGS1 study. Front Psychiatry. 2018;9. doi:10.3389/fpsyt.2018.00114
  • Hahm B-J, Shin Y-W, Shim E-J, et al. Depression and the vision-related quality of life in patients with retinitis pigmentosa. Br J Ophthalmol. 2008;92(5):650–654. doi:10.1136/bjo.2007.127092
  • Qian Y, Glaser T, Esterberg E, Acharya NR. Depression and visual functioning in patients with ocular inflammatory disease. Am J Ophthalmol. 2012;153(2):370–378.e2. doi:10.1016/j.ajo.2011.06.028
  • Cumurcu T, Cumurcu BE, Celikel FC, Etikan I. Depression and anxiety in patients with pseudoexfoliative glaucoma. Gen Hosp Psychiatry. 2006;28(6):509–515. doi:10.1016/j.genhosppsych.2006.09.004
  • Kong X, Yan M, Sun X, Xiao Z. Anxiety and depression are more prevalent in primary angle closure glaucoma than in primary open-angle glaucoma. J Glaucoma. 2015;24(5):e57–e63. doi:10.1097/IJG.0000000000000025
  • Koenes SG, Karshmer JF. Depression: a comparison study between blind and sighted adolescents. Issues Ment Health Nurs. 2000;21(3):269–279. doi:10.1080/016128400248086
  • Bolat N, Doğangün B, Yavuz M, Demir T, Kayaalp L. Depression and anxiety levels and self-concept characteristics of adolescents with congenital complete visual impairment. Turk Psikiyatri Derg. 2011;22(2):77–82.
  • Bakhla AK, Sinha VK, Verma V, Sarkhel S. Prevalence of psychiatric morbidity in visually impaired children. Indian Pediatr. 2011;48(3):225–227. doi:10.1007/s13312-011-0050-9
  • Donoyama N, Takeda F. Mental Health and Related Factors among Massage Practitioners with Visual Impairment. Ind Health. 2007;45(2):191–198. doi:10.2486/indhealth.45.191
  • Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144(2):238–244.e1. doi:10.1016/j.ajo.2007.04.048
  • Garaigordobil M, Bernarás E. Self-concept, self-esteem, personality traits and psychopathological symptoms in adolescents with and without visual impairment. Span J Psychol. 2009;12(1):149–160. doi:10.1017/S1138741600001566
  • Congdon N, O’Colmain B, Klaver CCW, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–485. doi:10.1001/archopht.122.4.477
  • Varma R, Vajaranant TS, Burkemper B, et al. Visual impairment and blindness in adults in the United States: demographic and geographic variations from 2015 to 2050. JAMA Ophthalmol. 2016;134(7):802. doi:10.1001/jamaophthalmol.2016.1284
  • Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health. 2014;2(2):e106–e116. doi:10.1016/S2214-109X(13)70145-1
  • Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annu Rev Clin Psychol. 2009;5(1):363–389. doi:10.1146/annurev.clinpsy.032408.153621
  • Wassink-Vossen S, Collard RM, Wardenaar KJ, et al. Trajectories and determinants of functional limitations in late-life depression: a 2-year prospective cohort study. Eur Psychiatry. 2019;62:90–96. doi:10.1016/j.eurpsy.2019.09.003
  • Court H, McLean G, Guthrie B, Mercer SW, Smith DJ. Visual impairment is associated with physical and mental comorbidities in older adults: a cross-sectional study. BMC Med. 2014;12:1. doi:10.1186/s12916-014-0181-7
  • Horowitz A. Major and subthreshold depression among older adults seeking vision rehabilitation services. Am J Geriatric Psychiatry. 2005;13(3):180–187. doi:10.1176/appi.ajgp.13.3.180
  • van der Aa HPA, Comijs HC, Penninx BWJH, van Rens GHMB, van Nispen RMA. Major depressive and anxiety disorders in visually impaired older adults. Invest Ophthalmol Vis Sci. 2015;56(2):849–854. doi:10.1167/iovs.14-15848
  • Frank CR, Xiang X, Stagg BC, Ehrlich JR. Longitudinal associations of self-reported vision impairment with symptoms of anxiety and depression among older adults in the United States. JAMA Ophthalmol. 2019;137(7):793. doi:10.1001/jamaophthalmol.2019.1085
  • van der Aa HPA, Hoeben M, Rainey L, van Rens GHMB, Vreeken HL, van Nispen RMA. Why visually impaired older adults often do not receive mental health services: the patient’s perspective. Qual Life Res. 2015;24(4):969–978. doi:10.1007/s11136-014-0835-0
  • Evans JR, Fletcher AE, Wormald RPL. Depression and anxiety in visually impaired older people. Ophthalmology. 2007;114(2):283–288. doi:10.1016/j.ophtha.2006.10.006
  • Hayman KJ, Kerse NM, La Grow SJ, Wouldes T, Robertson MC, Campbell AJ. Depression in older people: visual impairment and subjective ratings of health. OptometryVision Sci. 2007;84(11):1024–1030. doi:10.1097/OPX.0b013e318157a6b1
  • Heesterbeek TJ, van der Aa HPA, van Rens GHMB, Twisk JWR, van Nispen RMA. The incidence and predictors of depressive and anxiety symptoms in older adults with vision impairment: a longitudinal prospective cohort study. Ophthalmic Physiol Optics. 2017;37(4):385–398. doi:10.1111/opo.12388
  • Holloway EE, Sturrock BA, Lamoureux EL, Keeffe JE, Rees G. Depression screening among older adults attending low-vision rehabilitation and eye-care services: characteristics of those who screen positive and client acceptability of screening: depression screening in low vision. Australas J Ageing. 2015;34(4):229–234. doi:10.1111/ajag.12159
  • Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma. 2008;17(7):552–557. doi:10.1097/IJG.0b013e31816299d4
  • Nollett CL, Bray N, Bunce C, et al. High prevalence of untreated depression in patients accessing low-vision services. Ophthalmology. 2016;123(2):440–441. doi:10.1016/j.ophtha.2015.07.009
  • Jones GC, Rovner BW, Crews JE, Danielson ML. Effects of depressive symptoms on health behavior practices among older adults with vision loss. Rehabil Psychol. 2009;54(2):164–172. doi:10.1037/a0015910
  • Chou K-L. Combined effect of vision and hearing impairment on depression in older adults: evidence from the English Longitudinal Study of Ageing. J Affect Disord. 2008;106(1–2):191–196. doi:10.1016/j.jad.2007.05.028
  • Augustin A, Sahel J-A, Bandello F, et al. Anxiety and Depression Prevalence Rates in Age-Related Macular Degeneration. Invest Opthalmol Visual Sci. 2007;48(4):1498. doi:10.1167/iovs.06-0761
  • Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults. Front Aging Neurosci. 2013;5. doi:10.3389/fnagi.2013.00056
  • Mathew RS, Delbaere K, Lord SR, Beaumont P, Vaegan MMC. Depressive symptoms and quality of life in people with age- related macular degeneration: quality of life and AMD. Ophthalmic Physiol Optics. 2011;31(4):375–380. doi:10.1111/j.1475-1313.2011.00848.x
  • Rovner BW, Casten RJ. Neuroticism predicts depression and disability in age-related macular degeneration. J Am Geriatr Soc. 2001;49(8):1097–1100. doi:10.1046/j.1532-5415.2001.49215.x
  • Rovner BW, Casten RJ. Activity loss and depression in age-related macular degeneration. Am J Geriatric Psychiatry. 2002;10(3):305–310. doi:10.1097/00019442-200205000-00010
  • Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108(10):1893–1900. doi:10.1016/S0161-6420(01)00754-0
  • Dawson SR, Mallen CD, Gouldstone MB, Yarham R, Mansell G. The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data. BMC Ophthalmol. 2014;14:1. doi:10.1186/1471-2415-14-78
  • Soubrane G. Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch Ophthalmol. 2007;125(9):1249. doi:10.1001/archopht.125.9.1249
  • Kempen GIJM, Ballemans J, Ranchor AV, van Rens GHMB, Zijlstra GAR. Erratum to: the impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living older adults seeking vision rehabilitation services. Qual Life Res. 2012;21(8):1413. doi:10.1007/s11136-011-0103-5
  • Cosh S, Carrière I, Daien V, Tzourio C, Delcourt C, Helmer C. Sensory loss and suicide ideation in older adults: findings from the Three-City cohort study. Int Psychogeriatrics. 2019;31(1):139–145. doi:10.1017/S104161021800056X
  • Forsell Y, Jorm AF, Winblad B. Suicidal thoughts and associated factors in an elderly population. Acta Psychiatr Scand. 1997;95(2):108–111. doi:10.1111/j.1600-0447.1997.tb00382.x
  • Kim Y, Kwak Y, Kim J. The association between suicide ideation and sensory impairment among elderly Koreans. Aging Ment Health. 2015;19(7):658–665. doi:10.1080/13607863.2014.989812
  • Waern M. Burden of illness and suicide in elderly people: case-control study. BMJ. 2002;324(7350):1355. doi:10.1136/bmj.324.7350.1355
  • Rim TH, Lee CS, Lee SC, Chung B, Kim SS. Epidemiologic Survey Committee of the Korean Ophthalmological Society. Influence of visual acuity on suicidal ideation, suicide attempts and depression in South Korea. Br J Ophthalmol. 2015;99(8):1112–1119. doi:10.1136/bjophthalmol-2014-306518
  • Stensman R, Sundqvist-Stensman U-B. Physical disease and disability among 416 suicide cases in Sweden. Scand J Soc Med. 1988;16(3):149–153. doi:10.1177/140349488801600305
  • Meyer-Rochow VB, Hakko H, Ojamo M, Uusitalo H, Timonen M. Suicides in visually impaired persons: a nation-wide register-linked study from finland based on thirty years of data. Voracek M, ed. PLoS One. 2015;10(10):e0141583. doi:10.1371/journal.pone.0141583
  • Lam BL. Reported visual impairment and risk of suicide: the 1986-1996 national health interview surveys. Arch Ophthalmol. 2008;126(7):975. doi:10.1001/archopht.126.7.975
  • Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex Visual Hallucinations in the Visually Impaired. Surv Ophthalmol. 2003;48(1):58–72. doi:10.1016/S0039-6257(02)00414-9
  • Brown GC. Visual symptoms associated with choroidal neovascularization: photopsias and the charles bonnet syndrome. Arch Ophthalmol. 1992;110(9):1251. doi:10.1001/archopht.1992.01080210069027
  • Lepore FE. Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways. Neurology. 1990;40(3 Part1):444. doi:10.1212/WNL.40.3_Part_1.444
  • Vaphiades MS, Celesia GG, Brigell MG. Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology. 1996;47(2):408–417. doi:10.1212/WNL.47.2.408
  • Schadlu AP, Schadlu R, Shepherd JB. Charles Bonnet syndrome: a review. Curr Opin Ophthalmol. 2009;20(3):219–222. doi:10.1097/ICU.0b013e328329b643
  • Schwartz TL, Vahgei L. Charles Bonnet syndrome in children. J Am Assoc Ped Ophthalmol Strabismus. 1998;2(5):310–313. doi:10.1016/S1091-8531(98)90091-X
  • Tan CSH, Sabel BA, Goh K-Y. Visual hallucinations during visual recovery after central retinal artery occlusion. Arch Neurol. 2006;63(4):598. doi:10.1001/archneur.63.4.598
  • Schultz G, Melzack R. Visual hallucinations and mental state: a study of 14 Charles Bonnet syndrome hallucinators. J Nerv Ment Dis. 1993;181(10):639–643. doi:10.1097/00005053-199310000-00011
  • Holroyd S, Rabins PV, Finkelstein D, Lavrisha M. Visual hallucinations in patients from an ophthalmology clinic and medical clinic population. J Nerv Ment Dis. 1994;182(5):273–276. doi:10.1097/00005053-199405000-00004
  • Cole MG. Charles Bonnet hallucinations: a case series *. Can J Psychiatry. 1992;37(4):267–270. doi:10.1177/070674379203700411
  • Giridhar P, Dandona R, Prasad MN, Kovai V, Dandona L. Fear of blindness and perceptions about blind people. The Andhra Pradesh Eye Disease Study. Indian J Ophthalmol. 2002;50(3):239–246.
  • De Leo D, Hickey PA, Meneghel G, Cantor CH. Blindness, Fear of Sight Loss, and Suicide. Psychosomatics. 1999;40(4):339–344. doi:10.1016/S0033-3182(99)71229-6
  • Wong EYH, Guymer RH, Hassell JB, Keeffe JE. The Experience of Age-related Macular Degeneration. J Vis Impair Blind. 2004;98(10):629–640. doi:10.1177/0145482X0409801007
  • Teitelman J, Copolillo A. Psychosocial Issues in Older Adults’ Adjustment to Vision Loss: findings From Qualitative Interviews and Focus Groups. Am J Occupational Ther. 2005;59(4):409–417. doi:10.5014/ajot.59.4.409
  • Alma MA, van der Mei SF, Melis-Dankers BJM, van Tilburg TG, Groothoff JW, Suurmeijer TPBM. Participation of the elderly after vision loss. Disabil Rehabil. 2011;33(1):63–72. doi:10.3109/09638288.2010.488711
  • Thurston M, Thurston A, McLeod J. Socio-emotional effects of the transition from sight to blindness. Br J Visual Impairment. 2010;28(2):90–112. doi:10.1177/0264619609359304
  • Rees G, Xie J, Holloway EE, et al. Identifying Distinct Risk Factors for Vision-Specific Distress and Depressive Symptoms in People With Vision Impairment. Invest Opthalmol Visual Sci. 2013;54(12):7431. doi:10.1167/iovs.13-12153
  • Nollett CL, Ryan B, Bray N, et al. Depressive symptoms in people with vision impairment: a cross-sectional study to identify who is most at risk. BMJ Open. 2019;9(1):e026163. doi:10.1136/bmjopen-2018-026163
  • Wallhagen MI, Strawbridge WJ, Shema SJ, Kurata J, Kaplan GA. Comparative Impact of Hearing and Vision Impairment On Subsequent Functioning. J Am Geriatr Soc. 2001;49(8):1086–1092. doi:10.1046/j.1532-5415.2001.49213.x
  • Brown JC, Goldstein JE, Chan TL, Massof R, Ramulu P. Characterizing functional complaints in patients seeking outpatient low-vision services in the United States. Ophthalmology. 2014;121(8):1655–1662.e1. doi:10.1016/j.ophtha.2014.02.030
  • McDermott S, Moran R, Platt T, Dasari S. Health conditions among women with a disability. J Women’s Health. 2007;16(5):713–720. doi:10.1089/jwh.2007.0363
  • Mitra M, Wilber N, Allen D, Walker DK. Prevalence and correlates of depression as a secondary condition among adults with disabilities. Am J Orthopsychiatry. 2005;75(1):76–85. doi:10.1037/0002-9432.75.1.76
  • Okoro CA, Strine TW, Balluz LS, Crews JE, Mokdad AH. Prevalence and correlates of depressive symptoms among United States adults with disabilities using assistive technology. Prev Med. 2010;50(4):204–209. doi:10.1016/j.ypmed.2010.01.008
  • Robinson-Whelen S, Taylor HB, Hughes RB, Nosek MA. Depressive symptoms in women with physical disabilities: identifying correlates to inform practice. Arch Phys Med Rehabil. 2013;94(12):2410–2416. doi:10.1016/j.apmr.2013.07.013
  • Bookwala J, Lawson B. Poor vision, functioning, and depressive symptoms: a test of the activity restriction model. The Gerontologist. 2011;51(6):798–808. doi:10.1093/geront/gnr051
  • Crews JE, Jones GC, Kim JH. Double jeopardy: the effects of comorbid conditions among older people with vision loss. J Vis Impair Blind. 2006;100(1_suppl):824–848. doi:10.1177/0145482X0610001S07
  • Erickson W, Lee C, von Schrader S Disability Statistics from the American Community Survey (ACS). Cornell University Yang-Tan Institute (YTI); 2017. www.disabilitystatistics.org. Accessed November 12, 2020.
  • Kok RM, Reynolds CF. Management of depression in older adults: a review. JAMA. 2017;317(20):2114. doi:10.1001/jama.2017.5706
  • Chang-Quan H, Xue-Mei Z, Bi-Rong D, Zhen-Chan L, Ji-Rong Y, Qing-Xiu L. Health status and risk for depression among the elderly: a meta-analysis of published literature. Age Ageing. 2010;39(1):23–30. doi:10.1093/ageing/afp187
  • Lenze EJ, Rogers JC, Martire LM, et al. The association of late-life depression and anxiety with physical disability: a review of the literature and prospectus for future research. Am J Geriatric Psychiatry. 2001;9(2):113–135. doi:10.1097/00019442-200105000-00004
  • Carrière I, Delcourt C, Daien V, et al. A prospective study of the bi-directional association between vision loss and depression in the elderly. J Affect Disord. 2013;151(1):164–170. doi:10.1016/j.jad.2013.05.071
  • Gillies MC, Campain A, Barthelmes D, et al. Long-Term outcomes of treatment of neovascular age-related macular degeneration. Ophthalmology. 2015;122(9):1837–1845. doi:10.1016/j.ophtha.2015.05.010
  • Senra H, Ali Z, Balaskas K, Aslam T. Psychological impact of anti-VEGF treatments for wet macular degeneration—a review. Graefe’s Arch Clin Exp Ophthalmol. 2016;254(10):1873–1880. doi:10.1007/s00417-016-3384-0
  • Senra H, Balaskas K, Mahmoodi N, Aslam T. Experience of Anti-VEGF treatment and clinical levels of depression and anxiety in patients with wet age-related macular degeneration. Am J Ophthalmol. 2017;177:213–224. doi:10.1016/j.ajo.2017.03.005
  • Ford DE. Optimizing outcomes for patients with depression and chronic medical illnesses. Am J Med. 2008;121(11):S38–S44. doi:10.1016/j.amjmed.2008.09.012
  • Verger P, Lions C, Ventelou B. Is depression associated with health risk-related behaviour clusters in adults? Eur J Public Health. 2009;19(6):618–624. doi:10.1093/eurpub/ckp057
  • Richa S, Yazbek J-C. Ocular adverse effects of common psychotropic agents: a review. CNS Drugs. 2010;24(6):501–526. doi:10.2165/11533180-000000000-00000
  • Lavoie M-P, Lam RW, Bouchard G, et al. Evidence of a biological effect of light therapy on the retina of patients with seasonal affective disorder. Biol Psychiatry. 2009;66(3):253–258. doi:10.1016/j.biopsych.2008.11.020
  • Hébert M, Dumont M, Lachapelle P. Electrophysiological evidence suggesting a seasonal modulation of retinal sensitivity in subsyndromal winter depression. J Affect Disord. 2002;68(2–3):191–202. doi:10.1016/S0165-0327(00)00192-0
  • Bubl E, Ebert D, Kern E, van Elst LT, Bach M. Effect of antidepressive therapy on retinal contrast processing in depressive disorder. Br J Psychiatry. 2012;201(2):151–158. doi:10.1192/bjp.bp.111.100560
  • Fam J, Rush AJ, Haaland B, Barbier S, Luu C. Visual contrast sensitivity in major depressive disorder. J Psychosom Res. 2013;75(1):83–86. doi:10.1016/j.jpsychores.2013.03.008
  • Rovner BW, Zisselman PM, Shmuely-Dulitzki Y. Depression and disability in older people with impaired vision: a follow-up study. J Am Geriatr Soc. 1996;44(2):181–184. doi:10.1111/j.1532-5415.1996.tb02436.x
  • Lansingh V, Carter M, Ulldemolins A, Valencia L, Eckert K. Social inequalities in blindness and visual impairment: a review of social determinants. Indian J Ophthalmol. 2012;60(5):368. doi:10.4103/0301-4738.100529
  • Ehrlich JR, Stagg BC, Andrews C, Kumagai A, Musch DC. Vision impairment and receipt of eye care among older adults in low- and middle-income countries. JAMA Ophthalmol. 2019;137(2):146. doi:10.1001/jamaophthalmol.2018.5449
  • Wang W, Yan W, Müller A, Keel S, He M. Association of socioeconomics with prevalence of visual impairment and blindness. JAMA Ophthalmol. 2017;135(12):1295. doi:10.1001/jamaophthalmol.2017.3449
  • Perruccio AV, Badley EM, Trope GE. A Canadian population-based study of vision problems: assessing the significance of socioeconomic status. Can J Ophthalmol. 2010;45(5):477–483. doi:10.3129/i10-061
  • Gilbert CE, Shah SP, Jadoon MZ, et al. Poverty and blindness in Pakistan: results from the Pakistan national blindness and visual impairment survey. BMJ. 2008;336(7634):29–32. doi:10.1136/bmj.39395.500046.AE
  • Kirtland KA, Saaddine JB, Geiss LS, et al. Geographic disparity of severe vision loss - United States, 2009-2013. MMWR Morb Mortal Wkly Rep. 2015;64(19):513–517.
  • Wah W, Earnest A, Sabanayagam C, et al. Composite measures of individual and area-level socio-economic status are associated with visual impairment in Singapore. PLoS One. 2015;10(11):e0142302. doi:10.1371/journal.pone.0142302
  • Yip JLY, Luben R, Hayat S, et al. Area deprivation, individual socioeconomic status and low vision in the EPIC-Norfolk Eye Study. J Epidemiol Community Health. 2014;68(3):204–210. doi:10.1136/jech-2013-203265
  • Zheng Y, Lamoureux E, Finkelstein E, et al. Independent impact of area-level socioeconomic measures on visual impairment. Invest Opthalmol Visual Sci. 2011;52(12):8799. doi:10.1167/iovs.11-7700
  • Cockburn N, Steven D, Lecuona K, et al. Prevalence, causes and socio-economic determinants of vision loss in Cape Town, South Africa. Atashili J, ed. PLoS One. 2012;7(2):e30718. doi:10.1371/journal.pone.0030718
  • Jalali MDM, Moussavi MS, Yazdi SAA, Fadardi JS. Effectiveness of rational emotive behavior therapy on psychological well-being of people with late blindness. J Rational Emot Ognitive Behav Ther. 2014;32(4):233–247. doi:10.1007/s10942-014-0191-6
  • Chou C-F, Beckles GLA, Zhang X, Saaddine JB. Association of socioeconomic position with sensory impairment among us working-aged adults. Am J Public Health. 2015;105(6):1262–1268. doi:10.2105/AJPH.2014.302475
  • Rahi JS, Cumberland PM, Peckham CS. Visual function in working-age adults early life influences and associations with health and social outcomes. Ophthalmology. 2009;116(10):1866–1871. doi:10.1016/j.ophtha.2009.03.007
  • Dandona R. Moderate visual impairment in India: the Andhra Pradesh eye disease study. Br J Ophthalmol. 2002;86(4):373–377. doi:10.1136/bjo.86.4.373
  • Yan X, Chen L, Yan H. Socio-economic status, visual impairment and the mediating role of lifestyles in developed rural areas of China. Zhou X, ed. PLoS One. 2019;14(4):e0215329. doi:10.1371/journal.pone.0215329
  • Wilson CJ, Rust G, Levine R, Alema-Mensah E. Disparities in vision impairment among adults in the United States. Ethn Dis. 2008;18(2Suppl2):S2-242–246.
  • Varma R, Chung J, Foong AWP, Torres M, Choudhury F, SP A. Four-year incidence and progression of visual impairment in Latinos: the Los Angeles Latino eye study. Am J Ophthalmol. 2010;149(5):713–727. doi:10.1016/j.ajo.2009.12.011
  • Nollett CL, Bray N, Bunce C, et al. Depression in Visual Impairment Trial (DEPVIT): a randomized clinical trial of depression treatments in people with low vision. Invest Opthalmol Visual Sci. 2016;57(10):4247. doi:10.1167/iovs.16-19345
  • Julia Salinas RS, Aishat Mohammed NHF, Warren JZ. Primary open-angle glaucoma in individuals of african descent: a review of risk factors. J Clin Exp Ophthalmol. 2015;06:04. doi:10.4172/2155-9570.1000450
  • Abou-Gareeb I, Lewallen S, Bassett K, Courtright P. Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthalmic Epidemiol. 2001;8(1):39–56. doi:10.1076/opep.8.1.39.1540
  • Clayton JA, Davis AF. Sex/gender disparities and women’s eye health. Curr Eye Res. 2015;40(2):102–109. doi:10.3109/02713683.2014.986333
  • Doyal L, Das-Bhaumik RG. Sex, gender and blindness: a new framework for equity. BMJ Open Ophthalmol. 2018;3(1):e000135. doi:10.1136/bmjophth-2017-000135
  • Mganga H, Lewallen S, Courtright P. Overcoming gender inequity in prevention of blindness and visual impairment in Africa. Middle East Afr J Ophthalmol. 2011;18(2):98–101. doi:10.4103/0974-9233.80695
  • van der Aa HPA, Xie J, Rees G, et al. Validated prediction model of depression in visually impaired older adults. Ophthalmology. 2016;123(5):1164–1166. doi:10.1016/j.ophtha.2015.11.028
  • Albert P. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015;40(4):219–221. doi:10.1503/jpn.150205
  • Baxter AJ, Scott KM, Ferrari AJ, Norman RE, Vos T, Whiteford HA. Challenging the myth of an “epidemic” of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010. Depress Anxiety. 2014;31(6):506–516. doi:10.1002/da.22230
  • Leigh IW, Powers L, Vash C, Nettles R. Survey of psychological services to clients with disabilities: the need for awareness. Rehabil Psychol. 2004;49(1):48–54. doi:10.1037/0090-5550.49.1.48
  • Ruggeri M, Bonetto C, Lasalvia A, et al. Feasibility and effectiveness of a multi-element psychosocial intervention for first-episode psychosis: results from the cluster-randomized controlled GET UP PIANO trial in a catchment area of 10 million inhabitants. Schizophr Bull. 2015;41(5):1192–1203. doi:10.1093/schbul/sbv058
  • Taylor HR, Pezzullo ML, Nesbitt SJ, Keeffe JE. Costs of interventions for visual impairment. Am J Ophthalmol. 2007;143(4):561–565.e1. doi:10.1016/j.ajo.2006.10.055
  • Ishii K, Kabata T, Oshika T. The impact of cataract surgery on cognitive impairment and depressive mental status in elderly patients. Am J Ophthalmol. 2008;146(3):404–409. doi:10.1016/j.ajo.2008.05.014
  • Nyman SR, Gosney MA, Victor CR. Emotional well-being in people with sight loss: lessons from the grey literature. Br J Visual Impairment. 2010;28(3):175–203. doi:10.1177/0264619610374171
  • Brennan M, Horowitz A, Reinhardt JP, Cimarolli V, Benn DT, Leonard R. In their own words: strategies developed by visually impaired elders to cope with vision loss. J Gerontol Soc Work. 2001;35(1):107–129. doi:10.1300/J083v35n01_08
  • Penn E, Tracy DK. The drugs don’t work? antidepressants and the current and future pharmacological management of depression. Ther Advan Psychopharmacol. 2012;2(5):179–188. doi:10.1177/2045125312445469
  • Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177–187. doi:10.1016/S0738-3991(02)00032-0
  • Brody BL, Williams RA, Thomas RG, Kaplan RM, Chu RM, Brown SI. Age-related macular degeneration: A randomized clinical trial of a self-management intervention. Ann Behav Med. 1999;21(4):322–329. doi:10.1007/BF02895965
  • Brody BL. Self-management of age-related macular degeneration and quality of life: a randomized controlled trial. Arch Ophthalmol. 2002;120(11):1477. doi:10.1001/archopht.120.11.1477
  • Brody BL. Self-management of age-related macular degeneration at the 6-month follow-up: a randomized controlled trial. Arch Ophthalmol. 2005;123(1):46. doi:10.1001/archopht.123.1.46
  • Brody BL, Roch-Levecq A-C, Kaplan RM, Moutier CY, Brown SI. Age-related macular degeneration: self-management and reduction of depressive symptoms in a randomized, controlled study: AMD self-management and reduced depressive symptoms. J Am Geriatr Soc. 2006;54(10):1557–1562. doi:10.1111/j.1532-5415.2006.00881.x
  • Girdler SJ, Boldy DP, Dhaliwal SS, Crowley M, Packer TL. Vision self-management for older adults: a randomised controlled trial. Br J Ophthalmol. 2010;94(2):223–228. doi:10.1136/bjo.2008.147538
  • Rees G, Xie J, Chiang PP, et al. A randomised controlled trial of a self-management programme for low vision implemented in low vision rehabilitation services. Patient Educ Couns. 2015;98(2):174–181. doi:10.1016/j.pec.2014.11.008
  • Gath D, Mynors-Wallis L. Problem-solving treatment in primary care. In Clark DM, Fairburn CG, editors. Science and Practice of Cognitive Behaviour Therapy. Oxford, UK: Oxford University Press; 1997:415–431.
  • Rovner BW, Casten RJ, Hegel MT, Leiby BE, Tasman WS. Preventing depression in age-related macular degeneration. Arch Gen Psychiatry. 2007;64(8):886. doi:10.1001/archpsyc.64.8.886
  • Mynors-Wallis L. Problem-solving treatment: evidence for effectiveness and feasibility in primary care. Int J Psychiatry Med. 1996;26(3):249–262. doi:10.2190/0HVY-CD2F-0KC7-FVTB
  • Mynors-Wallis LM. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ. 2000;320(7226):26–30. doi:10.1136/bmj.320.7226.26
  • Rovner BW, Casten RJ. Preventing late-life depression in age-related macular degeneration. Am J Geriatric Psychiatry. 2008;16(6):454–459. doi:10.1097/JGP.0b013e31816b7342
  • Holloway E, Sturrock B, Lamoureux E, et al. Delivering problem-solving treatment in low-vision rehabilitation: A pilot feasibility study. Rehabil Psychol. 2018;63(3):349–356. doi:10.1037/rep0000217
  • Rovner BW, Casten RJ, Hegel MT, et al. Improving function in age-related macular degeneration. Ophthalmology. 2013;120(8):1649–1655. doi:10.1016/j.ophtha.2013.01.022
  • Stelmack J. Emergence of a rehabilitation medicine model for low vision service delivery, policy, and funding. Optometry J Am Optometric Assoc. 2005;76(5):318–326. doi:10.1016/S1529-1839(05)70315-8
  • Horowitz A, Reinhardt JP, Boerner K. The effect of rehabilitation on depression among visually disabled older adults. Aging Ment Health. 2005;9(6):563–570. doi:10.1080/13607860500193500
  • Horowitz A, Brennan M, Reinhardt JP, MacMillan T. The impact of assistive device use on disability and depression among older adults with age-related vision impairments. J Gerontol B Psychol Sci Soc Sci. 2006;61(5):S274–S280. doi:10.1093/geronb/61.5.S274
  • Rovner BW, Casten RJ, Hegel MT, et al. Low vision depression prevention trial in age-related macular degeneration. Ophthalmology. 2014;121(11):2204–2211. doi:10.1016/j.ophtha.2014.05.002
  • Kamga H, McCusker J, Yaffe M, et al. Self-care tools to treat depressive symptoms in patients with age-related eye disease: a randomized controlled clinical trial: self-care tools and depressive symptoms. Clin Experiment Ophthalmol. 2017;45(4):371–378. doi:10.1111/ceo.12890
  • Kendrick T, Pilling S. Common mental health disorders — identification and pathways to care: NICE clinical guideline. Br J General Pract. 2012;62(594):47–49. doi:10.3399/bjgp12X616481
  • Van’t Veer-tazelaar PJ, van Marwijk HWJ, van Oppen P, et al. Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. Arch Gen Psychiatry. 2009;66(3):297. doi:10.1001/archgenpsychiatry.2008.555
  • van der Aa HPA, van Rens GHMB, Comijs HC, et al. Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial. BMJ. 2015:h6127. doi:10.1136/bmj.h6127.
  • van der Aa HPA, van Rens GHMB, Bosmans JE, Comijs HC, van Nispen RMA. Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial. BMC Psychiatry. 2017;17:1. doi:10.1186/s12888-017-1437-5
  • Wahl H-W, Kämmerer A, Holz F, et al. Psychosocial intervention for age-related macular degeneration: a pilot project. J Vis Impair Blind. 2006;100(9):533–544. doi:10.1177/0145482X0610000905
  • van der Aa HPA, Margrain TH, van Rens GHMB, Heymans MW, van Nispen RMA. Psychosocial interventions to improve mental health in adults with vision impairment: systematic review and meta-analysis. Ophthalmic Physiol Optics. 2016;36(5):584–606. doi:10.1111/opo.12313
  • Senra H, Macedo AF, Nunes N, Balaskas K, Aslam T, Costa E. Psychological and psychosocial interventions for depression and anxiety in patients with age-related macular degeneration: a systematic review. Am J Geriatric Psychiatry. 2019;27(8):755–773. doi:10.1016/j.jagp.2019.03.001
  • Tuttle DW, Tuttle NR. Self-Esteem and Adjusting with Blindness: The Process of Responding to Life’s Demands. 3rd ed. Charles C. Thomas; 2004.
  • Bradley P, Mitchell J, Bradley C. Peer support for people newly diagnosed with macular degeneration: A pilot study. Int Congress Series. 2005;1282:211–215. doi:10.1016/j.ics.2005.04.001
  • Kleinschmidt JJ. Older adults’ perspectives on their successful adjustment to vision loss. J Vis Impair Blind. 1999;93(2):69–81. doi:10.1177/0145482X9909300202
  • A-Tjak JGL, Davis ML, Morina N, et al. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom. 2015;84(1):30–36. doi:10.1159/000365764
  • Veehof MM, Trompetter HR, Bohlmeijer ET, Schreurs KMG. Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cogn Behav Ther. 2016;45(1):5–31. doi:10.1080/16506073.2015.1098724
  • Bourne RRA, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Global Health. 2013;1(6):e339–e349. doi:10.1016/S2214-109X(13)70113-X